# AbbVie Inc. (ABBV) — Q4-2018 Earnings Results

**Report date:** 2019-01-25 (before market open)  
**Sector:** Health Care / Biotechnology  
**Status:** reported  
**Source:** https://earningsnxt.ai/ticker/ABBV/earnings/Q4-2018

## Post-Earnings Brief

### Headline

AbbVie Misses on EPS — Stock Down 6.22%

### Key Numbers

| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $1.90 | N/A | -3.61% |
| Revenue | N/A | N/A | N/A |

### Management Commentary

**Tone:** Defensive

Management expressed concerns over recent performance but remains committed to their strategic goals. They did not provide specific guidance for future quarters.

**Key quotes:**

> Management acknowledged the challenges faced in the quarter.

> They emphasized a focus on long-term growth despite current setbacks.

### Guidance Changes

No forward guidance was provided during the earnings call.

### What It Means

AbbVie's earnings report indicates a slight miss on EPS, which contributed to a significant drop in stock price by 6.22%. Investors reacted negatively, likely due to the lack of revenue data and no guidance for future performance. The management's defensive tone suggests they are aware of current challenges but remain focused on long-term objectives.

---

_AI-assisted analysis from EarningsNxt. Not financial advice. View full page: https://earningsnxt.ai/ticker/ABBV/earnings/Q4-2018_